26.04.2022 12:29:50

DGAP-AFR: PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

DGAP Preliminary announcement financial reports: PharmaSGP Holding SE / Preliminary announcement on the disclosure of financial statements
PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

26.04.2022 / 12:29
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


PharmaSGP Holding SE hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report

Language: German
Date of disclosure: April 28, 2022
Address: https://ir.pharmasgp.com/#Finanzberichte

Language: English
Date of disclosure: April 28, 2022
Address: https://ir.pharmasgp.com/en/#FinancialReports

Report Type: Annual financial report of the group

Language: German
Date of disclosure: April 28, 2022
Address: https://ir.pharmasgp.com/#Finanzberichte

Language: English
Date of disclosure: April 28, 2022
Address: https://ir.pharmasgp.com/en/#FinancialReports


26.04.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: PharmaSGP Holding SE
Lochhamer Schlag 21
82166 Gräfelfing
Germany
Internet: https://pharmasgp.com

 
End of News DGAP News Service

1335603  26.04.2022 

fncls.ssp?fn=show_t_gif&application_id=1335603&application_name=news&site_id=smarthouse

Analysen zu PharmaSGPmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

PharmaSGP 23,80 0,85% PharmaSGP